Antiviral

All articles by Antiviral

Gilead inks $100M partnership with Assembly Bio for antivirals

Lecia Bushak

October 17, 2023

3:26 pm

Gilead will pay $100 million upfront for the deal, which will involve developing therapies for herpes simplex virus and hepatitis B virus.

From Our Partners

Partner Content

How AI and first-party data is transforming pharma customer engagement

Using technology to improve audience segmentation, targeting and virtual interaction.

Partner Content

The importance of female representation in health

How to effect change and close the gender gap in healthcare.

Partner Content

The A100 Playbook Podcast | Real Chemistry: Visualizing the future: Art, science and AI innovation

Listen to Jack O’Brien of MM+M and Brandon Pletsch, president of scientific visualization at Real Chemistry, as they delve into the dynamic intersection of art, science and AI innovation in the field of scientific visualization.

Partner Content

Garbage in, garbage out — How health marketers can ensure the right information reaches patients and HCPs

This session with Justin Freid, chief marketing and innovation officer of CMI Media Group, and Daniel Nadler, founder of Open Evidence, will enlighten health brands to the possibilities of AI.

HAYMARKET MARKETING COMMUNICATIONS:

HAYMARKET MARKETING COMMUNICATIONS:

Quick Links

Antiviral

All articles by Antiviral

Gilead inks $100M partnership with Assembly Bio for antivirals

AI Deciphered: Discovering the Potential for Marketers and Communicators

From Our Partners

Partner Content

How AI and first-party data is transforming pharma customer engagement

Partner Content

The importance of female representation in health

Partner Content

The A100 Playbook Podcast | Real Chemistry: Visualizing the future: Art, science and AI innovation

Partner Content

Garbage in, garbage out — How health marketers can ensure the right information reaches patients and HCPs